Electrical activation of common bile duct nerves modulates sphincter of Oddi motility in the Australian possum  by Sonoda, Y. et al.
Electrical activation of common bile duct nerves modulates
sphincter of Oddi motility in the Australian possum
Y. SONODA, S. TAKAHATA, F. JABAR, A. C. SCHLOITHE, M. A. GRIVELL, C. M. WOODS,
M. E. SIMULA, J. TOOULI & G. T. P. SACCONE
Department of General & Digestive Surgery, Centre for Neuroscience, Flinders University, Flinders Medical Centre,
Bedford Park, South Australia, Australia 5042
Abstract
Background: Sphincter of Oddi (SO) motility is regulated by extrinsic and intrinsic nerves. The existence of neural circuits
between the SO and the proximal extrahepatic biliary tree has been reported, but they are poorly understood. Using electrical
field stimulation (EFS), we determined if a neural circuit exists between the common bile duct (CBD) and the SO in
anaesthetized Australian brush-tailed possums. Methods: The gallbladder, cystic duct or CBD were subjected to EFS with a
stimulating electrode. Spontaneous SO phasic waves were measured by manometry. Results: EFS at sites on the distal CBD
(12–20 mm proximal to the SO), but less commonly at more proximal CBD, evoked a variety of responses consisting of an
excitatory and/or inhibitory phase. Bi-phasic responses consisting of an excitation followed by inhibition were the most
common. Tri-phasic responses were also observed as well as excitation or inhibition only. These evoked responses were
blocked by topical application of local anaesthetic to the distal CBD or transection of the CBD. EFS at sites on the gallbladder
body, neck or cystic duct did not consistently evoke an SO response. Pretreatment with atropine or guanethidine reduced the
magnitude of the evoked response by about 50% (p50.05), pretreatment with hexamethonium had no consistent effect and
pretreatment with a nitric oxide synthase inhibitor increased the response. Discussion: A neural circuit(s) between the SO and
the distal CBD modulates SO motility. Damage to this area of the CBD during bile duct exploration surgery could adversely
affect SO motility.
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Introduction
The sphincter of Oddi (SO) is located at the junction of
the bile duct, pancreatic duct and duodenum, and
regulates the flow of bile and pancreatic juice into
the duodenum [1]. The SO also prevents reflux of
duodenal contents into the biliary and pancreatic
systems [1–3]. SO activity is controlled by extrinsic and
intrinsic nerves and gastrointestinal hormones [3–6].
Abnormalities in this complex neurohormonal control
may be manifested as SO dysfunction [7,8].
Numerous animal studies have described a relation-
ship between SO and duodenal motility. We have
previously shown that electrical field stimulation (EFS)
of the duodenum elicits an excitatory SO response
in the Australian possum in vivo [9] and in vitro [10],
providing functional evidence for an intramural
neural pathway(s) between the SO and duodenum.
Morphological studies using neural tracing by Padbury
et al. [11] and Mawe et al. [12] demonstrated the
presence of direct neural connections between the SO
and duodenum in the Australian possum and the
guinea pig. Furthermore, Kennedy et al. [13,14]
showed that the duodenal–SO neural circuit includes
predominantly intrinsic primary afferent neurons
from the duodenal myenteric plexus. These findings
support the existence of intrinsic neural connections
between the SO and the duodenum, with a role for
the duodenum in regulating SO motility.
The passage of bile into the duodenum requires the
coordinated motor activity of the gallbladder, the SO,
and the common bile duct (CBD) [1,3]. A reflex
between the gallbladder and the SO has been reported.
Wyatt [15] showed that electrical or mechanical
stimulation of the gallbladder reflexly inhibited phasic
contractions of the SO in dogs. Thune et al. [16] and
Shafik [17] demonstrated that distention of the gall-
bladder decreased SO pressure in humans and dogs,
suggesting that a local reflex between the SO and the
gallbladder might be important in the regulation of SO
motility.
The regulation of SO activity by the CBD, the
choledochosphincter reflex, has been implicated by
several reports. Thune et al. [18] demonstrated in cats
that the SO activity was altered by distending the CBD,
suggesting a homeostatic neural mechanism between
Correspondence: Gino T. P. Saccone, Department of General and Digestive Surgery, Flinders Medical Centre, Bedford Park, South Australia, Australia 5042.
Fax: +61 8 8204 5966. E-mail: gino.saccone@flinders.edu.au
HPB, 2005; 7: 303–312
ISSN 1365-182X print/ISSN 1477-2574 online # 2005 Taylor & Francis
DOI: 10.1080/13651820510037639
the SO and the CBD. Shafik [19] demonstrated
that increased CBD pressure by balloon distension
inhibited SO activity in dogs. The choledocho-
sphincter reflex is considered to regulate the opening of
the SO for the passage of bile from the bile duct to the
duodenum.
Characterization of neural pathways between the SO
and the CBD has not been described. Several neuro-
peptides have been observed in the pig, guinea pig and
possum CBD [20–24]; however, their role in the
regulation of SO motility is unclear. The overall aim of
this study was to investigate possible neural mechan-
isms responsible for the reflex between the CBD and
the SO. The specific aims were to (1) map the regions
of the CBD which upon EFS, evoke an SO response
and describe the types of SO responses observed;
(2) determine if the SO response involves cholinergic,
adrenergic or nitrergic neurotransmission; (3) deter-
mine if the connections between the CBD and SO are
extrinsic or intrinsic in origin; and (4) describe the
general neuronal topography of the CBD.
Methods
Animal preparation
The following studies were approved by the Animal
Welfare Committee of Flinders University. Australian
brush-tailed possums (Trichosurus vulpecula) of either
sex (n=61), median 1.9 kg, (range 1.5–2.3 kg body
weight) were used in this study. Animals were fasted for
18 h and anaesthesia was induced with intramuscular
xylazine (10 mg/kg Rompun; Bayer, Botany, NSW,
Australia) and ketamine (20 mg/kg Ketalar; Park
Davis, Caringbah, NSW, Australia). The left femoral
vein was cannulated and anaesthesia was maintained
for the duration of the experiment with a constant
infusion of sodium pentobarbitone (Nembutal
15–45 mg/kg/h; Boehringer Ingelheim, Atrarmon,
NSW, Australia) or sodium thiopentone (Pentothal
5–10 mg/kg/h; Abbott Australia, Kurnell, NSW,
Australia). Blood pressure was measured by a pressure
transducer (Transpac IV; Abbot Ireland, Sligo,
Republic of Ireland) via a catheter in the left femoral
artery. All animals were artificially ventilated with a
small animal ventilator (Phipps and Bird Inc., Rich-
mond, VA, USA). Body temperature was maintained
at 37C with a homeothermic heating blanket
(Harvard Apparatus, Holliston, MA, USA).
Intraperitoneal access was achieved by a mid-
abdominal incision. Following a small longitudinal
incision in the proximal CBD, a five-lumen manometry
catheter (0.9 mm OD, 0.2 mm ID) was inserted
into the SO. The manometry catheter was connected
to a minimally compliant pneumohydraulic pump
(Arndorfer Medical Specialities Inc., Greenvale, WI,
USA) and pressure transducers [25]. The pylorus was
ligated to prevent gastric emptying into duodenum. To
maintain the duodenum at a constant pressure, a
silastic catheter (5.0 mm OD, 3.0 mm ID) with one
end hole and several side holes 10 mm from the end,
was inserted into the duodenum 10 cm anal to the
papilla of Vater through a stab incision and secured by
a ligature.
The splenic artery was cannulated in a retrograde
direction with a catheter (0.5 mm OD, 0.2 mm ID) for
drug delivery. To deliver EFS, a silver bipolar electrode
(3 mm long poles, 2 mm apart, 0.6 mm diameter wire)
connected to a Grass SD9 stimulator (Grass Instru-
ments Inc., Quincy, MA, USA) was placed on CBD
(Figure 1). The blood pressure and SO manometry
were continuously recorded using a MacLab recording
system with Chart 3.5 software (ADInstruments Pty
Ltd, Castle Hill, NSW, Australia).
Experimental protocols
SO response to CBD EFS. Preliminary studies showed
that the EFS of different regions of the gallbladder and
cystic duct did not evoke a change in SO motility. In
contrast, EFS of the CBD, particularly the more distal
regions, did evoke changes in SO motility. The SO
response was not due to field spread as preliminary
experiments showed that crushing the CBD between
the site of EFS and the SO with silk ligatures abolished
the EFS-evoked SO response. The length of CBD
between the proximal edge of the SO and the bifurca-
tion of the hepatic duct was measured and the length
divided into quarters designated CBD regions A, B, C,
D (Figure 1). To determine which regions of the CBD
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Figure 1. Schematic diagram illustrating the key features of the
preparation used for functional studies. Upper panel: A five-lumen
manometry catheter was positioned in the sphincter of Oddi (SO)
via the common bile duct (CBD). The bi-polar stimulating electrode
used for electrical field stimulation is shown in relation to the segment
of the CBD. Lower panel: The length of the CBD in each preparation
was measured and each quarter of the length was designated as region
A to D, from the SO end.
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evoked a SO response upon EFS, in 14 animals the
position of the bipolar electrode was systematically
varied between these regions. A 30-min equilibration
period was allowed following each re-position of the
electrode before EFS (70 V, 0.2 ms duration for 40 s)
was applied. The EFS frequency was varied from 5 to
60 Hz to determine optimal frequency. The prepara-
tions were allowed to recover for at least 5 min between
successive bouts of EFS. It was found that EFS at
regions A and B produced the most consistent and
strongest SO responses; hence region A was generally
used for subsequent studies to define the neuronal
circuitry.
In some animals region A was obscured by
pancreatic tissue. Consequently region B was chosen as
the standard site for EFS. The EFS frequency response
data showed that SO responses to EFS frequencies of
20, 40 and 60 Hz were comparable, therefore a 40-Hz
stimulus frequency was adopted as standard for
subsequent experiments.
The effect of topical application of xylocaine. Histological
studies have demonstrated that the possum CBD does
not contain smooth muscle, but does contain numer-
ous nerve fibres and cell bodies [26]. To confirm that
the SO responses evoked by EFS of the appropriate
CBD regions were neural in origin, local anaesthetic
(1% xylocaine 0.5 ml; Astra Pharmaceuticals Pty Ltd,
North Ryde, NSW, Australia) was topically applied to
the CBD around the stimulating electrode, and EFS
was repeated 5 min after anaesthetic application (n=4
possums). Under these conditions direct EFS (70 V,
0.2 ms duration, 5 Hz for 5 s) of the SO evoked an
excitatory response, indicating that the xylocaine had
not spread to the SO.
CBD transection studies. To ascertain whether the
neural connections between the CBD and the SO were
intramural, the following CBD transection studies
were performed in another four possums. Following
confirmation of a SO response to EFS of an appro-
priate CBD region, the CBD distal to the electrode was
transected completely with the aid of a dissecting
microscope. Care was taken to ensure that the blood
supply to the tissue was intact. Then the EFS of the
appropriate CBD region was repeated 20 min later.
Definition of neuronal population. The types of neurons
mediating the SO response to EFS of the CBD were
investigated by determining the influence of several
antagonists. Atropine sulphate (30 mg/kg; Sigma
Chemical Co., St Louis, MO, USA; n=6) or hexa-
methonium bromide (30 mg/kg; Sigma, n=6) were
administered by intra-arterial bolus injections over
30 s as described previously [27]. No-nitro-L-arginine
methyl ester (L-NAME 1.0 mg/kg; Sigma; n=6) was
also administered by intra-arterial bolus injection over
30 s, at doses that produced a small increase in
blood pressure (115.3+5.3% of baseline; P50.05),
indicating that some level of nitric oxide synthase
inhibition had occurred. When a higher dose was
used, extremely high blood pressure resulted and
some animals died. Consequently the lower dose was
adopted. Guanethidine (10 mg/kg; Sigma; n=6) was
administered via intra-arterial bolus injection over
30 s [9].
Acute bilateral vagotomy and coeliac ganglion block. The
potential role of extrinsic innervation in the SO
response to CBD EFS was investigated by determining
the effect of acute bilateral cervical vagotomy (n=3) or
coeliac ganglion block (n=3) with local injection of
xylocaine (1%, 0.5 ml; Astra) on the magnitude of the
response elicited by EFS (40 Hz) at CBD region B.
Each animal was euthanased at the completion of the
experiment with a lethal dose of sodium pentobarbi-
tone (Lethabarb1; Arnolds of Reading, Baronia,
Victoria, Australia).
Analysis of records
EFS resulted in shortening of the SO, consequently
the recordings from the SO body were regarded as
the most stable and reliable for quantitation. The
area under the curve (AUC; mmHg.s) for a 60-s
interval immediately before an EFS event (baseline
activity) was measured and regarded as the control
AUC. Similarly, following administration of drugs and
stabilization of the SO activity, the drug-induced
change was quantified as AUC for a 60-s period and
expressed as a percentage of baseline. The duration of
the SO response evoked by EFS of the CBD region, i.e.
from the onset of the EFS to the return to baseline
activity (seconds), was measured. When complex SO
responses consisting of more than one phase were
evoked, the magnitude of each phase of the response
(AUC) was expressed as a percentage of the control
AUC (% control). However, pretreatment with atro-
pine, L-NAME or guanethidine altered the total
duration of the response to EFS in some animals,
although the duration of the response for the group was
not statistically altered. This situation precluded reli-
able quantitation of changes to individual phases of the
response when they were observed before treatment.
Based on the variation in the AUC of SO responses to a
standard EFS, increases in AUC 420% of control
were regarded as excitatory responses, and decreases
420% of control as inhibitory responses. Changes of
AUC 520% either above or below the control AUC
were regarded as no response. All data are presented as
means+SEM.
Immunohistochemistry and retrograde neural tracing
Nine possums were fasted for 18 h prior to use.
Anaesthesia was administered as described above
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and the cystic duct, CBD and SO were harvested
in toto. Animals were euthanased with an overdose
of Lethabarb1. The tissue was flushed of its
duodenal contents with phosphate-buffered saline
(PBS; 0.15 M NaCl in 0.01 M sodium phosphate, pH
7.2), placed in a Petri dish lined with Sylgard (Dow
Corning, Sydney, NSW, Australia) containing PBS
and the entire tissue was opened lengthwise and fixed
as a whole mount in modified Zamboni’s fixative (2%
formaldehyde and 15% saturated picric acid in 0.1 M
phosphate buffer, pH 7.0) overnight, at 4C. After
fixation, the tissue was rinsed thoroughly in PBS
several times.
To enhance the tissue penetration of antiserum, the
tissue was permeabilized with dimethyl sulphoxide
(3r10-min exposures, at room temperature) and then
rinsed in PBS. Indirect immunofluorescence techni-
ques using primary antiserum combined with a fluor-
escent-labelled secondary antiserum were employed.
In order to determine the total innervation patterns
and nerve cell body population, the tissues were
incubated at room temperature with the pan-
neuronal marker, rabbit anti-protein gene product
9.5 (PGP9.5, 1 : 400 dilution; Ultraclone, Isle of
Wight, UK), for 48 h (n=3). After several washes
with PBS, preparations were exposed overnight at
room temperature to the following species-specific
fluorescent secondary antiserum: indocarbocyanine
(CY3)-conjugated donkey anti-rabbit IgG (1 : 200
dilution; Jackson ImmunoResearch Labs Inc., West
Grove, PA, USA). All preparations were washed in
PBS before mounting in bicarbonate-buffered glycerol
(pH 8.6). Control experiments showed that omis-
sion of the primary antiserum abolished visible
labelling with the appropriate secondary antiserum
combination.
In order to establish whether direct neural con-
nections exist between the circular muscle of the SO
and the CBD and/or gallbladder, retrograde neural
tracing was performed in vitro. Another 6 animals
were anaesthetised as described above and a seg-
ment of duodenum with SO, CBD and gallbladder
was harvested en bloc. Animals were then euthanased
as described above. The distal SO circular muscle
was exposed and 1,10-didodecyl-3,3,3030-tetramethyl-
indocarbocyanine perchlorate (DiI; Molecular Probes,
Eugene, OR, USA) coated glass beads were applied.
The beads were removed after culture for 24 h, to
prevent penetration of the tracer into the underlying
tissues. The preparations were cultured for 4 days in
culture medium (DME F12 (Sigma), 10% fetal bovine
serum, 1.2 g/L NaHCO3, 1.8 mmol/L CaCl2, 2.5 mg/
ml amphotericin, 100 IU/ml penicillin, 20 mg/ml
gentamicin, 100 mg/ml streptomycin, buffered to pH
7.2), after which the preparations were fixed overnight
in modified Zamboni’s fixative at 4C. Whole mount
preparations were examined with epifluorescence
microscopy and the position of nerve cells was mapped
as described previously [28,29].
Statistical analysis
Statistical analysis was performed using the Wilcoxon
sum-rank test and unpaired t-test, as appropriate.
p50.05 was regarded as significant.
Results
EFS-evoked SO responses
All preparations displayed spontaneous phasic SO
contractions that were similar to those we have
described previously. In all, 80% of CBD EFS bouts
(181 of 224 bouts; n=14 animals) evoked an SO
response; however, the presence of a response was
dependent on the site of the CBD being stimulated and
the stimulus frequency. The evoked response was
composed of excitatory and/or inhibitory phases and
the responses could be divided into six general patterns
(Figure 2). Based on the systematic study of the SO
response to EFS at various CBD sites and stimulus
frequency (n=14 animals), a tri-phasic response was
the most complex and consisted of a brief initial inhi-
bition of the spontaneous phasic contractions,
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Figure 2. Sphincter of Oddi response to EFS of the CBD. (a) Tri-
phasic response (n=17). This response consists of an initial inhibi-
tion of the spontaneous phasic contractions, commencing with the
onset of EFS followed by an excitatory phase consisting of increased
phasic contractions. The third phase is inhibition of phasic contrac-
tions. (b) Bi-phasic-1 response (n=9). The first phase is inhibition of
phasic contractions, followed by an excitatory phase. (c) Bi-phasic-2
response (n=42). The first phase is excitation of phasic contractions,
followed by an inhibitory phase. (d) Excitation-only response
(n=23). (e) Inhibition-only response (n=21). (f) Irregular response
(n=69). This response is a mixture of excitatory and inhibitory
responses. (g) No response (n=43). In each panel, the EFS event
(70 V, 0.2 ms, 40 s) is indicated by the solid bar.
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commencing with the onset of EFS followed by an
excitatory response then by inhibition of phasic
contractions (Figure 2a). This type of response made
up 9.4% of the total responses recorded. Two types of
bi-phasic responses were observed and designated as
bi-phasic-1 and bi-phasic-2. Bi-phasic-1 responses
consisted of an inhibition, followed by an excitation of
phasic contractions (Figure 2b) whereas bi-phasic-2
responses (which were more common) were the
converse, i.e. excitation followed by an inhibition
phasic contractions (Figure 2c). These responses
represented 5.0% and 23.3% of the total responses,
respectively. The fourth type of response, excitation-
only, consisted of only an excitation of phasic
contractions (Figure 2d), and represented 12.7% of
the total responses. Inhibition-only responses were the
fifth type observed and consisted of only an inhibition
of phasic contractions (Figure 2e), and represented
11.6% of the total responses observed. Irregular
responses were the sixth type (Figure 2f), consisted of a
combination of excitation and inhibition of phasic
contractions and represented 38.1% of the total
responses. In addition, in every animal EFS of a
number of CBD sites, primarily in the proximal
regions, did not evoke any change in SO phasic
contractions (43 of 224 EFS bouts; Figure 2g). In
summary, EFS of the CBD evoked a range of SO
responses consisting of excitatory and/or inhibitory
phases.
Stimulus frequency and CBD region
The total number of responses evoked by EFS (data
from all EFS sites combined) were similar irrespective
of the stimulus frequency (n=14). For EFS stimulus
frequencies of 5, 20, 40 and 60 Hz, SO responses were
evoked by 73.2+4.1, 78.6+4.4, 82.1+4.1 and
89.3+4.3% of the EFS bouts, respectively. The region
of the CBD subject to EFS was important in relation to
evoked SO responses. The number of SO responses
evoked by EFS at CBD regions A, B, C and D were 56,
56, 43 and 26 from a total of 56 bouts of EFS (n=14).
In summary, EFS at sites in the distal half of the CBD
(i.e. closer to the SO) always evoked an SO response,
whereas fewer responses were evoked from more
proximal sites.
Intramural nerves
Either topical application of xylocaine to the EFS site
or transection of the CBD between the EFS site and
the SO, eliminated the EFS-evoked SO response
(Figure 3), confirming the neural nature of the
response and the intramural location of the nerves.
Atropine, hexamethonium, L-NAME
and guanethidine pretreatment
The possible involvement of cholinergic, adrenergic
and nitrergic transmission was investigated by
pharmacological studies. Pretreatment with the
muscarinic receptor antagonist atropine (n=6) or with
guanethidine (n=6), which prevents release of cate-
cholamine from sympathetic nerves, reduced sponta-
neous SO activity to 63.4+8.4% and to 72.6+7.4% of
baseline, respectively (both p50.05). The adminis-
tration of the nicotinic receptor antagonist hexa-
methonium (n=6) or the non-selective nitric oxide
synthase inhibitor L-NAME (n=6) did not signifi-
cantly alter the SO spontaneous phasic activity
(110.2+15.4% and 94.7+7.9% of baseline, respec-
tively).
Pretreatment with atropine (n=6) reduced the
magnitude of the EFS (CBD region B)-evoked (exci-
tatory) SO response from 166.1 + 35.7 to 82.4 +
7.0% of baseline (Figure 4a, b). In contrast, the appl-
ication of hexamethonium (n=6) did not consist-
ently alter the magnitude of the EFS-evoked response
(167.0+9.5% compared with 179.7+16.9% baseline
after treatment) (Figure 5). Administration of hexa-
methonium did not modify the EFS-evoked bi-phasic-
2 SO response in three animals (Figure 5a), increased
the response in two other animals (Figure 5b) and
decreased it in one other animal (Figure 5c).
Pretreatment with L-NAME (n=6) either enhanced
the excitatory response or in cases where inhibitory
responses were evoked prior to pretreatment, abolished
these responses (n=3; Figure 6a, b). The net effect was
an 80% increase in the magnitude of the EFS-evoked
response (160.6+28.3% compared with 291.4+
70.7% baseline after treatment; p50.05). The effect of
guanethidine pretreatment (n=6) was similar to that
produced by atropine (Figure 4c, d). The magnitude of
the EFS-evoked SO response for the group was
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Figure 3. Effect of topical xylocaine application and CBD transec-
tion on the SO response to EFS of the CBD. (a) Topical application
of xylocaine (n=4) to CBD region B essentially blocks the bi-phasic-
2 SO response to EFS of CBD. (b). After transection of the CBD
(n=4), the bi-phasic-2 SO response to EFS of CBD region B is
blocked. The solid bar represents the EFS event (70 V, 0.2 ms,
40 s).
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reduced from 153.4+12.1 to 76.5+17.8% of base-
line; p50.05). In three animals, the excitatory phase of
the bi-phasic-2 response was reduced and in the other
three animals, the excitation response was completely
abolished by guanethidine pretreatment. In summary,
the SO responses evoked by EFS of the CBD involve
cholinergic (muscarinic and nicotinic), nitrergic and
adrenergic transmission.
Acute bilateral vagotomy and coeliac ganglion block
Both acute bilateral cervical vagotomy (n=3) and
coeliac ganglion block with xylocaine injections (n=3)
failed to significantly change the SO response to EFS of
CBD region B. The coeliac block did produce a
sustained increase in blood pressure (data not shown).
These data suggest that the SO response evoked by
EFS of the CBD does not involve complete vagal or
splanchnic reflexes.
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Figure 4. Effect of atropine or guanethidine pretreatment on the SO
response to EFS of the CBD. The magnitude of all SO responses to
EFS of the CBD region B was reduced after administration of atro-
pine (30 mg/kg, close i.a.). The bi-phasic-2 SO response evoked by
EFS prior to atropine administration was changed to either a tri-
phasic response (a; n=3) or an inhibition-only response (b; n=3).
All SO responses to EFS of the CBD region B were reduced after
intra-arterial bolus injection of guanethidine (10 mg/kg). The
bi-phasic-2 SO response evoked by EFS prior to guanethidine
administration remained, with a reduction in the magnitude of the
excitatory phase (c; n=3). In another three animals, however, the
excitatory phase was completely eliminated following guanethidine
pretreatment with a reduction in the duration of the inhibitory phase,
although an increase in contraction frequency was noted (d). The
solid bar represents the EFS event (70 V, 0.2 ms, 40 s).
Hexamethonium
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Figure 5. Inconsistent effect of hexamethonium pretreatment on the
SO response to EFS of the CBD region B. The administration of
hexamethonium did not modify the EFS-evoked bi-phasic-2 SO
response in three animals (a), increased the response in two other
animals (b) and decreased it in one other animal (c). The solid bar
represents the EFS event (70 V, 0.2 ms, 40 s).
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Figure 6. Effect of L-NAME pretreatment on the SO response to
EFS of CBD region B. All SO responses to EFS are increased after
administration of L-NAME. The bi-phasic-2 SO responses remained
in three animals (a), but were changed to excitation-only responses in
three other animals (b). The solid bar represents the EFS (70 V,
0.2 ms, 40 s).
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Immunohistochemistry and retrograde tracing
Immunohistochemistry using the pan-neuronal
marker PGP9.5 revealed a rich network of fibres in the
CBD, which included some major nerve trunks and a
serosal ganglionated plexus (Figure 7). Quantitation of
the number of cell bodies relative to regions of the
CBD revealed 35, 24, 22 and 17 nerve cell bodies in
CBD regions A, B, D and D, respectively (n=2). This
distribution of nerve cell bodies is similar to the
distribution of the CBD sites which evoked SO
responses.
The possible direct connection between the SO
circular muscle and the CBD was assessed by retro-
grade neural tracing. No DiI-labelled neurons were
observed in the CBD or gallbladder, indicating the
absence of direct projections from the CBD to the SO.
Importantly, a total of 329 neurons were labelled with
DiI within the duodenum and SO and the majority
were located within 5 mm of the DiI application site. In
summary, the immunohistochemical data demonstrate
an abundant innervation in the CBD and the distri-
bution of cell bodies is similar to the distribution of the
CBD regions which evoked an SO response upon EFS.
The data from the retrograde tracing studies are
consistent with synaptic connections between the CBD
and the SO circular muscle.
Discussion
The present study has demonstrated the existence of
intramural neural connections between the CBD and
the SO. Electrical activation of these nerves produced
complex changes in SO motility that consisted of
excitatory and/or inhibitory phases. The activation of a
neural pathway is more prominent in the distal regions
of the CBD and the SO response includes cholinergic,
adrenergic and nitrergic components. Immunohisto-
chemical studies revealed a rich innervation in the
CBD consisting of an abundance of nerve fibres, some
major nerve trunks and a serosal ganglionated plexus.
Retrograde tracing studies failed to demonstrate direct
neural connections between the SO circular muscle
and the CBD. These data suggest that the neural
pathway is intramural, multi-synaptic and probably
intrinsic in origin, although the precise route of the
pathway is unclear.
There are several possible neural reflex pathways
that could be activated under the conditions described
here. Wyatt [15] was the first to report a reflex between
the SO and gallbladder. Subsequent studies in the cat
by Thune et al. [18] using fluid distension showed that
the pressure in the gallbladder and more proximal
segment of the CBD influenced SO motility. These
authors suggested the existence of a homeostatic
mechanism operating during the inter-digestive period
which involve the autonomic nervous system and
provided evidence of an inhibitory drive to the SO from
nerves in the CBD. More recently, Shafik [19]
demonstrated a similar change in canine SO motility in
response to the balloon distension of the gallbladder
and this reflex was not influenced by bilateral truncal
vagotomy. As we were unable to evoke an SO response
following EFS of the gallbladder, cystic duct and
usually the more proximal segment of the CBD, this
suggests that the neural pathway we have described
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Figure 7. Innervation of the CBD. All regions of the CBD had nerve cell bodies in ganglia and an abundance of nerve fibres. Possum CBDs
were fixed as whole mounts and immunohistochemically labelled with the pan-neuron marker, PGP 9.5. Panels a, b, c and d correspond to
CBD regions A, B, C and D as described in Figure 1. The arrows indicate ganglia, the arrowhead indicates a major nerve trunk, NF denotes
nerve fibres, and an asterisk designates a blood vessel. Scale bar=1 mm.
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may be different to those reported by Wyatt [15] and
Thune et al. [16].
On the other hand, our data are in agreement with
the recent report from Shafik [17], who demonstrated
that the canine SO pressure decreased transiently after
balloon dilatation of the CBD. This response was
blocked by the administration of local anaesthetic to
either the CBD or the SO, suggesting the existence of a
choledochosphincteric inhibitory reflex. In the present
study, both excitatory and inhibitory SO responses
were elicited and this may be a reflection of the non-
specific activation of excitatory and inhibitory nerves
achieved by EFS or the status of the SO neural circuits
at the time of EFS. Presumably under physiological
conditions, either the excitatory or inhibitory phases
may be selectively activated or both components may
be activated and the integration of both signals dictates
the motor activity of the SO. We attempted to stimu-
late this neural pathway with more physiologically
relevant stimuli such as fluid distension of the CBD or
perfusion of the CBD with bile, but these manipula-
tions failed to alter SO motility. Similarly, we applied
capsaicin to the serosa and luminal surfaces of the
CBD to activate sensory neurons (vagal or spinal) that
might be located in the CBD, but no change in spon-
taneous SO activity was observed. Our studies
demonstrated that the pathway is prominent in the
distal half of the CBD, a similar region distended by
Shafik [17]. Previous studies have not systematically
addressed the location of the pathway within different
regions of the CBD.
The neural nature of the SO response to EFS of the
CBD was confirmed by blockade of the SO response
following application of local anaesthetic to the EFS
site or transection of the CBD between the EFS site
and SO. The intramural location of these nerves is
suggested from the transection data; however, neither
the use of local anaesthetic nor transection can distin-
guish between neural pathways that are located within
the neural plexus that exists in the possum CBD, nerve
trunks that are located in the serosa layer of the CBD or
nerves associated with the vasculature of the CBD. The
involvement of gastrointestinal peptides is unlikely due
to the rapid onset of the SO responses.
We explored the possibility that EFS of the CBD
may involve the vagus nerve. The vagal innervation of
the SO is via the pylorus and a hepatic branch [30,31].
As acute bilateral cervical vagotomy did not modify the
evoked SO response, this seems unlikely. However, the
EFS of the CBD could activate the efferent vagal fibres
(autodromic stimulation), the afferent fibres (anti-
dromic stimulation) or collateral reflexes if located in
this region of the CBD. Similarly we considered a
spinal reflex as the origin of the neural pathway under
investigation. Injection of local anaesthetic into the
coeliac ganglion failed to modify the evoked SO
response despite producing a sustained increase in
blood pressure. It is possible that the coeliac block was
incomplete and that any residual active neurons could
mediate the evoked SO response. Many nerves derived
from the coeliac ganglion are considered to accompany
the hepatic artery [32]. In preliminary studies we found
that similar SO responses could be evoked by EFS of
the hepatic artery but the fact that these responses were
not blocked by application of local anaesthetic to the
CBD suggests that the route of this pathway is not via
the CBD. We have attempted to study the EFS CBD
evoked response in vitro; however, this has been
unsuccessful, despite the confirmation of viable nerves
within the SO by direct EFS of the SO and also acti-
vation of the duodenal–SO reflex.
Both atropine and guanethidine reduced the EFS-
evoked SO excitatory response; however, the nature of
the route of administration does not allow discrimi-
nation between neural and smooth muscle receptors.
Previous immunohistochemical studies in the guinea
pig and the possum SO have demonstrated numerous
cholinergic neurons and abundant fibres containing
tyrosine hydroxylase/dopamine b-hydroxylase in the
ganglionated plexus [33–35]. There is considerable
evidence based on morphological and electro-
physiological data that sympathetic nerves target SO
ganglia [36]. Numerous tyrosine hydroxylase im-
munoreactive nerve fibres are present in the possum
CBD [35] as well as many nerve fibres and cell bodies
immunopositive for nitric oxide synthase and
substance P [24]. Pharmacological studies using SO
smooth muscle preparations from a number of species,
including the possum, suggest that activation of a-
adrenergic and cholinergic muscarinic receptors
enhance SO contractile activity, whilst activation of b-
adrenergic receptors reduces SO contractile activity
[37–40]. In the possum, these receptors are believed
to be located primarily on the smooth muscle.
However, the fact that some EFS-evoked excitatory
response still remained after atropine or guanethidine
treatment is consistent with the involvement of one
or more other excitatory neurotransmitters, such as
tachykinins or ATP. On the other hand, in the present
study the SO response evoked by EFS of the CBD was
augmented by L-NAME administration, indicating
that nitric oxide is involved in the SO inhibitory
response. Baker et al. [41] demonstrated that nitric
oxide is the major NANC neurotransmitter in possum
SO. The present pharmacological studies indicate that
cholinergic, adrenergic and nitrergic transmission is
involved in this neural pathway.
Application of hexamethonium did influence the
EFS-evoked SO response but not in a consistent
manner; however, effects were observed in about half
the animals. These data suggest the involvement of
nicotinic receptors in the pathway, implying a multi-
synaptic pathway. This conclusion is supported by the
finding that retrograde tracing experiments failed to
reveal direct neural connections between the CBD and
the SO.
Overall, our data are consistent with at least two
models describing the CBD EFS-evoked SO responses
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and these models are not mutually exclusive. In one
model, EFS activates both excitatory and inhibitory
nerves located in the CBD, which constitute one or
more multi-synaptic pathways to the SO, with the net
SO motor output determined by the interaction of
these inputs at the level of the SO myenteric plexus. As
retrograde tracing studies from the SO circular muscle
failed to reveal neurons in the CBD, direct connection
to the smooth muscle is unlikely and favours a multi-
synaptic connection with the SO myenteric plexus. In
the second model, the neural output from the CBD is
uniform (i.e. a single class of neurons such as vagal
afferents) and synapse to one or more nerve circuits
within the SO myenteric plexus which then influences
SO motor activity. The activation of excitatory and/or
inhibitory nerve circuits occurs within the SO myen-
teric plexus with the magnitude and duration of the
final SO motor output determined by the integration of
these signals. In this model, the CBD nerves could
synapse at one or more sites within the SO.
The clinical implications of these findings are
evident in patients in whom the bile duct is divided, i.e.
liver transplantation or bile duct injury. The neuronal
connections which regulate SO motility may also be
divided or damaged and hence dysmotility of the SO
results. This finding is particularly evident following
end-to-end anastomoses in patients undergoing liver
transplantation, where cholestasis due to SO dysfunc-
tion is a common finding.
In conclusion, we have provided evidence for one or
more neural pathways between the distal half of the
CBD and the SO. Electrical activation of this path-
way(s) evokes complex responses in the SO consisting
of excitation and/or inhibition of spontaneous phasic
activity. The physiological stimuli that activate this
pathway are unclear. Damage to the pathways during
bile duct exploration surgery and liver transplantation
could adversely affect SO motility.
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